From Nasdaq: 2025-04-02 09:14:00

Zacks.com features top stocks in Analyst Blog, including Amazon.com, Oracle Corp., and Merck & Co. Recent reports highlight Amazon’s growth in Prime and AWS, Oracle’s cloud infrastructure momentum, and Merck’s challenges in competitive market. Amazon’s net sales expected to increase by 8.6% in 2025, while Oracle and Merck face margin limitations due to increased competition.

Zacks Research Daily offers insights on stock performance, with Amazon.com showing a 4.1% gain in the past year. Oracle’s shares outperform the industry, driven by cloud infrastructure investments. Merck faces competitive pressure but continues to see growth in Keytruda sales. Despite challenges, Merck’s strong cancer pipeline remains a positive factor for future growth.

Zacks identifies 5 potential stocks set to double, handpicked by experts for high growth potential in 2024. Most picks are flying under Wall Street radar, offering a ground floor opportunity for investors. The latest recommendations from Zacks Investment Research highlight 7 Best Stocks for the Next 30 Days, including Amazon.com, Merck & Co., and Oracle Corporation.



Read more at Nasdaq: The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck